Written answers
Wednesday, 3 June 2020
Department of Health
Medicinal Products
Stephen Donnelly (Wicklow, Fianna Fail)
Link to this: Individually | In context | Oireachtas source
539. To ask the Minister for Health if there will be a new national medicine pricing agreement in 2020 and in place before the expiry of the existing agreement later in summer 2020; the engagements and negotiations that have taken place to date to reach a new agreement; the parties he engaged with in this regard; the estimated timeline for the conclusion of a new agreement; the negotiating structure; the parties that will be a party to this agreement; the processes to reach agreement; and if he will make a statement on the matter. [8451/20]
Simon Harris (Wicklow, Fine Gael)
Link to this: Individually | In context | Oireachtas source
The four-year Framework Agreement on the Supply and Pricing of Medicines commenced on 1 August 2016 and, under the terms of the agreement, shall continue in force until 31 July 2020, unless continued by mutual agreement of the parties.
The Agreement also provides that negotiations on any successor or replacement agreement should begin at least six months before the expiry of the term.
My Department, the HSE and the Irish Pharmaceutical Healthcare Association are in contact with each other, in the context of these specific provisions of the current Agreement and with a view to progressing the process of discussions on a successor agreement.
No comments